What traders must learn about Pfizer’s newest…
Pfizer’s PFE, -0.92% early-stage pipeline, although promising, continues to be too untimely to make…
Tag: medical treatments
Regeneron Stock Sinks on Disappointing Sales of Eylea…
Regeneron Pharmaceuticals inventory was tumbling after the drugs maker reported decrease gross…
Pfizer to Pull Back on Rare Disease Research
Pfizer is planning to drag again on early-stage analysis into remedies for uncommon illnesses,…
Moderna Stock Is Upgraded on Growth Opportunities Not…
Moderna was rising Monday after an analyst at Jefferies upgraded the inventory citing confidence…
Moderna Soared on Good News About Cancer Vaccine. Why…
Moderna inventory jumped by double digits Tuesday on constructive information in regards to the…
Novavax inventory rallies, whilst firm gives a dimmer…
Novavax Inc. on Tuesday tweaked its full-year gross sales outlook to the low finish of its…
Pfizer Stock Gains After Earnings, Strong Data on RSV…
A double whammy of fine information despatched Pfizer shares larger early Tuesday, respiratory life…
3 Things to Watch When Pfizer Reports Its Results
Pfizer is ready to report its earnings on Tuesday, every week and a half after an govt informed…
Dialysis firm DaVita inventory struggling worst day in…
Shares of DaVita Inc. plummeted in lively buying and selling Friday, towards their worst efficiency…
Pfizer sets new prices for its COVID-19 vaccines. The…
Pfizer Inc. PFE, +3.61% said Thursday that it plans to sell the COVID-19 shot it developed with…
Trending Now
